Comparison of the thiamine level in blood and erythrocyte transketolase activity in hemodialyzed and nondialyzed patients during recombinant human erythropoietin therapy

Mineral and Electrolyte Metabolism

Volumn 23, Issue 3-6, 1997, Pages 277-282

  Pietrzak, Irena ^a   Ba̧czyk, Kazimierz ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

End stage renal disease; Erythrocyte transketolase activity; Erythropoietin; Hemodialysis; Thiamine

Indexed keywords

RECOMBINANT ERYTHROPOIETIN; THIAMINE; TRANSKETOLASE;

ANEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; HEMODIALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; BLOOD PROTEINS; COMBINED MODALITY THERAPY; ERYTHROCYTES; ERYTHROPOIETIN, RECOMBINANT; EVALUATION STUDIES; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; THIAMINE; TRANSKETOLASE;

EID: 19244375705     PISSN: 03780392     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. Eschbach JW, Adamson JW: Anemia in end-stage renal disease. Kidney Int 1985;28:1-5.
2. Horina JH, Schwaberger G, Brussee H, Sauseng-Fellegger G, Holzer H, Krejs GJ: Increased red cell 2,3-diphosphoglycerate levels in haemodialysis patients treated with erythropoietin. Nephrol Dial Transplant 1993;8:1219-1222.
3. Kokot F, Wiecek A: Endocrine changes in chronic dialysis patients; in Maher JF (ed): Replacement of Renal Function by Dialysis, ed 3. Dordrecht, Kluwer, 1989, pp 953-971.
4. Krawczyk W, Dmoszyńska A, Ledwozyw A, Soroka-Wojtaszko M: Influence of human recombinant erythropoietin on platelet phospholipids in haemodialysed patients. Acta Haematol Pol 1993;24:327-331.
5. Krawczyk W, Dmoszyńska A, Ledwozyw A, Marczewski K: Human erythropoietin changes fatty acids composition of blood platelet phospholipids in hemodialyzed patients. Nephron 1995;69:355.
6. Manitius J, Szołkiewicz M, Myśliwska J, Zorena K, Myśliwski A, Jakubowski Z, Łysiak-Szydłowska W, Rutkowski B: Influence of nonhematological doses of erythropoietin on lipid-carbohydrate metabolism and life quality in hemodialysis patients. Nephron 1995;69:363-364.
7. Stafensen G, Aunsholt NA: Does erythropoietin cause hormonal changes in haemodialysis patients? Nephrol Dial Transplant 1993;8:1215-1218.
8. Suzuki Y: Focus on erythropoietin: Effects on red cell enzymatic activity. 25th Congr EDTA-ERA. Madrid, 1988, p 4.
9. Brin M,Ostahever AS: The effect of thiamine deficiency on the activity of erythrocyte hemolysate transketolase. J Nutr 1960;71:273-281.
10. Horecker BL, Smyrniotis PZ: Coenzyme function of thiamine pyrophosphate in pentose phosphate metabolism. J Am Chem Soc 1953;75:1009.
11. Kopple JD, Dirige OV, Jacob M, Wang M, Swendseid ME: Transketolase activity in red blood cells in chronic uremia. Irans Am Soc Artif Intern Organs 1972;18:250-256.
12. Racker E, De La Haba G, Leder IG: Thiamine pyrophosphate, coenzyme of transketolase. J Am Chem Soc 1953;75:1010-1011.
13. Balestri PL, Rindi P, Biagini M, Giovannetti S: Effects of uremic serum urea, creatinine, and methylguanidine on glucose metabolism. Clin Sci 1972;42:395-404.
14. Cohen BD, Stein IM, Bonas JE: Guanidinosuccinic aciduria in uremia. Am J Med 1968;45:63-68.
15. Kurijama M, Mizuma A, Yokomine R, Igata A, Otuji Y: Erythrocyte transketolase in uremia. Clin Chim Acta 1980;108:169-177.
16. Lonergan ET, Semar M, Lange K: Transketolase activity in uremia. Arch Intern Med 1970;126:851-854.
17. Lonergan ET, Semar M, Sterzel RB, Treser G, Needle MA, Voyles BS, Lange K: Erythrocyte transketolase activity in dialyzed patients: A reversible metabolic lesion of uremia. N Engl J Med 1971;284:1399-1403.
18. Gentile MG, Porrini M, Manna GM, Ciceri R, Cofano F, Simonnetti P, Amico GD: Water and fat soluble vitamins status in chronic renal insufficiency patients; in Guarnieri G, Panzetta G, Toigo G (eds): Metabolic and Nutritional Abnormalities in Kidney Disease. Contrib Nephrol. Basel, Karger, 1992, vol 98, pp 89-97.
19. Pietrzak I, Baczyk K, Kubiak W: Recombinant human crythropoietin administration improves thiamine content in blood and erythrocyte transketolase activity in pre-dialysed patients. Ann Univ Mariae Curie-Sklodowska 1994;48:29-37.
20. Blum KU, Merkel D: Bemerkungen zum Nachweis des Thiamin in Serum mit der Thiochrom Methode. Z Klin Chem Klin Biochem 1974;10:437-439.
21. Bruns FH, Dünwald E, Nattmann E, Über den Stoffwechsel von Riboso-5-phosphat in Hämolysaten. III: Quantitative Bestimmung von Sedoheptulose-7-phosphat und einige Eigenschaften der Transketolase der Erythrocyten und des Blutserums. Biochem Z 1958;330:497-502.
22. Dische Z: Qualitative and quantitative colorimetric determination of heptose. J Biol Chem 1953;204:983-997.
23. 31P-NMR spectroscopy (abstract). 27th Congr EDTA-ERA, Vienna, 1990, p 253.
24. Bommer J, Barth HP, Zeier M, Mandelbaum A, Bommer G, Ritz E, Reichel H, Novaek R: Efficacy comparison of intravenous and subcutaneous recombinant human erythropoietin administration in hemodialysis patients; in Gurland HJ, Moran J, Samtleben W, Scigalla P, Wieczorek L (eds): Erythropoietin in Renal and Non-Renal Anemias. Contrib Nephrol. Basel Karger, 1991, vol 88, pp 136-143.